Metropolis Healthcare

Metropolis Healthcare Beats FY26 Revenue Guidance; Targets 28% EBITDA Margin by FY28

Metropolis Healthcare FY26 organic revenue grows 13.7%, beating 12-13% guidance. Management targets 27-28% EBITDA margins by FY28 through productivity gains.

Metropolis Healthcare · 14 May 2026, 4:30 PM IST